Cancer-associated cachexia, the wasting syndrome that erodes muscle, fat and physical resilience in many people with advanced cancer, has long resisted treatment. Now, researchers at the Korea Advanced Institute of Science and Technology (KAIST) report a preclinical strategy that targets the disorder from an unexpected location: the brainstem. In tumor-bearing mice, an RNA-based therapy designed to silence a neural receptor preserved body weight, muscle mass, fat stores and physical function, while dramatically improving survival even after cachexia had already developed.

The study was conducted by a joint team led by Minho Shong and Jinkuk Kim of KAIST’s Graduate School of Medical Science and Engineering, in collaboration with the KAIST faculty startup THOR Therapeutics. Their approach focuses on the biological circuit formed by growth differentiation factor 15, or GDF15, and its receptor, GFRAL. GDF15 is a signaling protein released in elevated amounts during several disease states, including cancer. When it reaches the hindbrain and binds to GFRAL, it activates neural pathways associated with nausea, appetite suppression and profound metabolic changes.

Cachexia is more complex than ordinary weight loss. Patients can continue losing muscle and body fat even when food intake is adequate, because cancer and the host response to cancer disrupt the systems that regulate energy use, inflammation and tissue maintenance. The resulting decline can weaken immunity, reduce mobility and make chemotherapy more difficult to tolerate. Although the syndrome affects an estimated 50 to 80 percent of people with cancer, available treatments have generally focused on stimulating appetite or providing nutritional support. Such measures may increase food intake temporarily, but they do not necessarily halt the breakdown of muscle or correct the underlying metabolic disturbance.

The KAIST researchers reasoned that the GDF15–GFRAL pathway could act as a central command system for this wasting response. GDF15 produced in the body circulates to the brainstem, where GFRAL is concentrated in a specialized region known as the area postrema and its surrounding neural circuitry. Once activated, this receptor can influence brain networks that control feeding behavior and autonomic metabolism. Rather than attempting to neutralize GDF15 throughout the body, the team chose to disable the receptor itself in the brainstem, preventing the signal from being received.

To accomplish this, the researchers developed antisense oligonucleotides, or ASOs, directed against Gfral messenger RNA. ASOs are short, chemically modified strands of nucleic acid engineered to bind a specific RNA sequence. When an ASO binds its target messenger RNA, cellular enzymes can promote its degradation or interfere with its processing, reducing production of the corresponding protein. In this case, the treatment lowered the supply of GFRAL receptors in the brainstem. The strategy therefore acts at the RNA stage, before the receptor is assembled and displayed on the surface of neural cells.

The experiments were performed in mice carrying tumors and showing established signs of cancer cachexia. This timing is important because many experimental interventions appear effective only when administered before severe wasting begins. According to the researchers, GFRAL silencing after cachexia had progressed substantially reduced the loss of muscle and fat. Treated animals also showed restoration of metabolic functions that had deteriorated during tumor growth, suggesting that the intervention did more than increase appetite. It helped interrupt the physiological program driving the breakdown of energy reserves.

The most striking result involved survival. At approximately day 50, the endpoint used in the study, about 90 percent of the mice receiving the GFRAL-targeting ASO remained alive, compared with roughly 20 percent of untreated tumor-bearing animals. The treated mice retained greater body weight and muscle mass and performed better in measures of muscle function. These findings indicate that cachexia itself can be a major determinant of outcome in cancer-bearing organisms and that blocking its central signaling pathway may provide benefits beyond nutritional improvement.

The work does not yet establish whether the same treatment will be safe or effective in people. GFRAL signaling is involved in the body’s response to circulating stress signals, and manipulating a receptor in the brainstem requires careful assessment of neurological, cardiovascular, gastrointestinal and metabolic effects. Human cancers also vary widely in their production of GDF15, tumor location and inflammatory biology. Nevertheless, the results offer a mechanistically precise alternative to therapies that merely encourage patients to eat. By targeting the receptor rather than broadly suppressing the signaling protein, the ASO approach may eventually be combined with chemotherapy, immunotherapy or other cancer treatments.

The findings, published in Cell Reports Medicine, represent an early step toward translating a brain-directed RNA therapy for cachexia. The researchers plan further preclinical studies, along with development of manufacturing and quality-control systems, with the stated goal of beginning clinical development in cancer patients by 2030. If the biology can be reproduced safely in humans, silencing GFRAL could become an adjunct treatment intended to preserve physical function, extend treatment tolerance and improve survival. For now, however, the evidence remains limited to tumor-bearing mice, and the central challenge will be determining whether a signal that can be switched off experimentally can be controlled with equal precision in patients.

Subject of Research:
An antisense oligonucleotide therapy targeting brainstem GFRAL to treat cancer-associated cachexia in tumor-bearing mice.

Article Title:
Therapeutic Gfral silencing via antisense oligonucleotides ameliorates cancer-associated cachexia and extends survival in tumor-bearing mice

Web References:
https://doi.org/10.1016/j.xcrm.2026.102939

References:
Cell Reports Medicine, published 27 July 2026. DOI: 10.1016/j.xcrm.2026.102939

Image Credits:
KAIST

Keywords:
Cancer cachexia, GFRAL, GDF15, antisense oligonucleotides, RNA therapy, brainstem, muscle wasting, cancer metabolism, preclinical research, KAIST

Naked mole rats are weird. They spend their lives almost entirely underground, are largely insensitive to some kinds of pain, can persist without oxygen for a long time, rarely develop cancer, and can live past 30 years, which is decades longer than similarly sized rodents. They are also eusocial, like ants, bees, or termites—in a colony that can hold more than a hundred animals, only one female, the queen, breeds.

We didn’t know how exactly naked mole-rat queens stop other females from breeding. For a long time, our leading hypothesis was bullying and violence, but that may be a bit impractical, given their kingdoms are vast networks of tunnels that can stretch for up to three kilometers. But now a team of Lewin Lab scientists at Max Delbrück Center for Molecular Medicine in Berlin discovered it’s actually just one part of a sophisticated olfactory signaling program.

Running on smell

"It's very clear that mole rats actually have quite big noses and smell a lot," says Gary Lewin, a neurobiologist at the Max Delbrück Center for Molecular Medicine and senior author of the study. Naked mole rats have around 1200 olfactory receptor genes, more than mice (which have roughly 1,000 of them) and way more than the few hundred in humans. They're also blind. "They have to be able to navigate and move around without vision, so smell is one of those things that’s enhanced," Lewin said.

Read full article

Comments

Gut microbes are increasingly being viewed as hidden regulators of brain health, and a new study in Translational Psychiatry adds fuel to that idea by tracing a biochemical pipeline from the gut to stress-related mental disorders. The research, led by Yuan, Qin, Wu and colleagues, reports that metabolites produced—or shaped—by gut microbiota can influence developmental trajectories associated with anxiety- and stress-linked pathology.

Rather than focusing solely on which bacterial species are present, the team examined functional metabolic output. Using integrative approaches that combine microbiome profiling with metabolomic measurements, the researchers identified gut-derived compounds whose levels tracked with downstream markers relevant to stress vulnerability. The results suggest that microbial metabolism may act as an early biochemical “switch,” tuning how stress signals are processed later.

A key finding is that these microbial metabolites do not merely correlate with symptoms; they appear to modulate mechanisms tied to disorder emergence. The study proposes that certain metabolite patterns can reshape host signaling pathways implicated in stress reactivity, including processes that affect neurodevelopment and the maturation of stress-response circuits.

The work also highlights how microbial communities can influence the chemical environment of the gut, altering metabolite availability and thereby changing what reaches the systemic circulation. Once in contact with host tissues, these metabolites may interact with receptors or influence cellular pathways involved in inflammation control and neuronal function—two domains frequently linked to stress-related psychiatric conditions.

Importantly, the paper frames gut–brain communication as a developmentally time-sensitive phenomenon. By emphasizing “development of stress-related mental disorders,” the authors argue that microbial metabolite exposure during critical windows could bias the risk landscape long before clinical symptoms emerge.

Methodologically, the study leverages translational reasoning, connecting microbial metabolites to mechanistic readouts rather than stopping at taxonomic associations. This strategy strengthens the causal plausibility of a microbiota-driven metabolic model and provides candidate compounds that could be targeted in future interventions.

From a public-health perspective, the findings support the growing concept that dietary patterns, probiotics, or precision microbiome therapies might be designed to adjust metabolite production. Such interventions could potentially recalibrate stress susceptibility by shifting the gut’s chemical outputs toward more protective profiles.

As the field advances, the study’s DOI—10.1038/s41398-026-04154-8—marks another step toward metabolite-centered strategies for mental health, where gut chemistry becomes a lever for preventing stress-driven disorders.

Subject of Research: Gut microbiota-driven metabolites and stress-related mental disorders
Article Title: Gut microbiota-driven metabolites modulate the development of stress-related mental disorders.
Article References: Yuan, M., Qin, F., Wu, L. et al. (2026). Translational Psychiatry. https://doi.org/10.1038/s41398-026-04154-8
Image Credits: AI Generated
DOI: https://doi.org/10.1038/s41398-026-04154-8

A newly published study in Nature Metabolism reports that brown fat can act as a hub of molecular messaging, using secreted microRNAs to coordinate physiology across the body. Researchers focused on brown adipose tissue—well known for its role in thermogenesis—and asked whether it also participates in long-distance communication via RNA signals.

To visualize and track these messages, the team employed brown-fat–specific RNA labeling in living systems. This strategy allowed them to connect RNA production within adipocytes to downstream effects elsewhere, moving beyond correlations toward a clearer map of inter-organ RNA traffic.

The central finding is the presence of a communication network mediated by microRNAs released from brown fat. These small regulatory RNAs appear to travel beyond the tissue of origin and engage gene-regulatory pathways in other organs, effectively relaying information about metabolic state.

Functionally, the work supports a model in which microRNA “dispatch” from thermogenic fat tunes cellular programs in remote targets. Such programs likely involve post-transcriptional regulation, a process microRNAs are known to influence by pairing with complementary sequences in messenger RNAs.

Importantly, the approach does not treat microRNAs as generic circulating molecules. Instead, the labeling confirms their brown-fat origin and strengthens the link between secretory RNA dynamics and systemic physiological outcomes.

The study also highlights the specificity of the messaging: not all RNAs are equally represented, and the labeled microRNA repertoire points to organized, tissue-defined signaling rather than random leakage.

Beyond mapping pathways, the results carry implications for metabolic disease research. If brown fat microRNAs can reshape gene expression in other organs, manipulating these signals could offer a route to modulate energy balance, insulin sensitivity, or inflammatory tone.

For now, the findings provide a blueprint for how RNA labelling combined with tissue specificity can uncover hidden layers of endocrine-like communication. As techniques improve, the field may move toward a broader “RNA connectome” linking organ behavior through secreted regulatory molecules.

Researchers describe their results as evidence that brown fat is not only a metabolic engine but also an information broadcaster. In the evolving landscape of viral-style science news, this discovery underscores how tiny RNA molecules can orchestrate large-scale biological conversations.

Subject of Research: Inter-organ communication via secreted microRNAs from brown adipose tissue.

Article Title: Brown fat-specific RNA labelling reveals a network of inter-organ communication by secreted microRNAs.

Article References: Lino, M., Palermo-Ruiz, G., Efthymiou, V. et al. Brown fat-specific RNA labelling reveals a network of inter-organ communication by secreted microRNAs. Nat Metab (2026). https://doi.org/10.1038/s42255-026-01558-0

Image Credits: AI Generated

DOI: https://doi.org/10.1038/s42255-026-01558-0

In a groundbreaking study poised to reshape our understanding of Parkinson’s disease (PD), researchers have unveiled a complex molecular mechanism linking metabolic stress to the disruption of circadian rhythms, with far-reaching implications for neurodegenerative disorders. This deep dive into cellular bioenergetics identifies a glucose-responsive oscillation involving the AMP-activated protein kinase (AMPK), ten-eleven translocation methylcytosine dioxygenase 2 (TET2), and 5-hydroxymethylcytosine (5hmC) axis as a pivotal mediator of metabolic stress responses in the brain. The discovery connects metabolic alterations directly to circadian transcriptional regulation, thereby illuminating previously obscure pathways influencing the onset and progression of Parkinson’s disease.

At the heart of this research lies the energy-sensing enzyme AMPK, a master regulator of cellular metabolism that responds dynamically to changes in cellular energy levels, especially glucose availability. AMPK’s role extends beyond energy balance; it modulates numerous signaling pathways critical for maintaining cellular homeostasis. When glucose levels fluctuate, AMPK activity adjusts accordingly, triggering a cascade of epigenetic modifications mediated by TET2, an enzyme known for its involvement in DNA demethylation and gene expression regulation through oxidative modification of 5-methylcytosine. This AMPK-TET2 interaction sets the stage for rhythmic changes in 5hmC, a key epigenetic mark that fine-tunes circadian gene expression.

The circadian clock is a complex transcriptional network orchestrating daily physiological and behavioral rhythms. Its disruption has been increasingly implicated in neurodegenerative conditions, yet the molecular underpinnings linking metabolism, circadian dysregulation, and neuronal vulnerability have remained elusive. The researchers’ demonstration that metabolic stress-induced AMPK activation regulates TET2-dependent 5hmC oscillations provides a compelling mechanistic bridge. Through this mechanism, energy fluctuations dynamically shape the transcription of circadian genes, potentially disturbing neuronal homeostasis and contributing to PD pathogenesis.

This study utilized a combination of cutting-edge genomic, epigenomic, and proteomic techniques to unravel the dynamics of the AMPK-TET2-5hmC circuit. High-resolution temporal profiling revealed that the oscillations of 5hmC marks at key circadian gene loci are not static but fluctuate in response to metabolic cues. These fluctuations integrate signals of cellular energy status and translate them into rhythmic transcriptional outputs. Importantly, the investigators found that these oscillatory patterns are disrupted in experimental models of Parkinson’s disease, suggesting that the fidelity of metabolic circadian signaling is compromised in neurodegeneration.

A significant aspect of the findings is the direct link between glucose availability and neuronal epigenetic regulation. Metabolic stress, often characterized by reduced glucose uptake or utilization, is a hallmark of aging and neurodegenerative disease states. The AMPK-TET2-5hmC axis serves as a metabolic sensor and effector that translates glucose scarcity into epigenetic reprogramming, thus influencing gene networks that sustain neuronal survival and function. This axis might represent a critical checkpoint where metabolic perturbations exert long-lasting effects on the neuronal epigenome and transcriptome, thereby driving PD progression.

One of the most intriguing revelations of this research is the bidirectional nature of the relationship between metabolic stress and circadian transcription. Not only does metabolic status influence circadian gene expression via epigenetic modulation, but disruptions in circadian regulation feedback to exacerbate metabolic dysfunction. This feedback loop could create a vicious cycle that accelerates neurodegenerative processes, underscoring the importance of maintaining metabolic and circadian integrity for brain health.

The implications of this study extend beyond basic science, offering exciting therapeutic potential. Targeting the AMPK-TET2-5hmC axis may open new avenues for interventions aimed at restoring metabolic and circadian homeostasis in Parkinson’s disease patients. Pharmacological modulators of AMPK activity or epigenetic editors capable of fine-tuning 5hmC dynamics could serve as innovative strategies to halt or slow neurodegeneration. Moreover, optimizing glucose metabolism through lifestyle or pharmacological means might indirectly preserve epigenetic and circadian function, offering a multi-faceted approach to disease management.

The research also highlights the importance of integrating metabolic and epigenetic perspectives to fully capture the complexity of neurodegenerative diseases. Traditional approaches focusing solely on genetic or protein dysfunction have fallen short in explaining the multifactorial etiology and progression of Parkinson’s disease. By illuminating the interplay between energy metabolism and epigenetic regulation, this study sets a new paradigm that could drive future research towards more holistic models of brain pathology.

In addition to elucidating molecular mechanisms, the study provides valuable insights into the temporal dimension of Parkinson’s disease pathology. The rhythmic oscillations of 5hmC marks influenced by glucose and AMPK activity emphasize that timing and metabolic context are crucial factors in disease progression. This may explain the variability in symptom manifestation and disease course among patients and suggests that chronotherapeutic approaches—aligning treatment with the circadian system—could enhance clinical outcomes.

Technologically, the application of multi-omics profiling coupled with advanced computational modeling allowed the researchers to dissect complex regulatory networks with unprecedented precision. Such integrative methodologies are essential for capturing dynamic biological processes that span different molecular layers and timescales. This approach underscores the future direction of biomedical research, where systems biology and temporal dynamics take center stage in unraveling disease mechanisms.

Furthermore, this study draws attention to the overlooked role of 5-hydroxymethylcytosine in the adult brain. Traditionally regarded as mere intermediates in DNA demethylation, 5hmC marks are now recognized as stable epigenetic modifications with distinct regulatory functions. Their oscillatory behavior in response to metabolic cues reveals them as critical mediators linking extracellular environmental factors to nuclear transcriptional machinery, thereby influencing neuronal fate and function.

The association of metabolic stress with circadian dysregulation through the AMPK-TET2-5hmC circuitry also provides a plausible explanation for the observed links between lifestyle factors—such as diet, sleep patterns, and physical activity—and Parkinson’s disease risk. Disruptions in any of these factors can alter glucose metabolism and circadian rhythms, potentially perturbing the delicate balance maintained by this molecular axis and predisposing individuals to neurodegeneration.

Importantly, the study’s findings could redefine biomarker discovery in Parkinson’s disease. Epigenetic oscillations of 5hmC, detectable in neuronal tissues and potentially biofluids, might serve as dynamic indicators of metabolic-circadian health and disease state. This could facilitate earlier diagnosis, tracking of disease progression, and evaluation of therapeutic interventions—ushering in a new era of precision medicine tailored to the metabolic and epigenetic status of patients.

Altogether, the elucidation of the glucose-responsive AMPK-TET2-5hmC oscillation offers a transformative lens through which to understand the intersection of metabolism, epigenetics, and circadian biology in Parkinson’s disease. By identifying a molecular conduit that links metabolic stress to circadian transcriptional misregulation, this research paves the way for innovative diagnostic and therapeutic strategies. As metabolic and circadian dysfunction climb into prominence as central pathogenic drivers, targeted modulation of this axis may hold the key to altering the trajectory of neurodegenerative diseases for millions worldwide.

This pioneering work heralds a new frontier in neuroscience, where cellular energetics, epigenetic remodeling, and circadian rhythms converge to shape neuronal destiny. Understanding and harnessing these complex oscillatory mechanisms offers unprecedented hope for combating the devastating impacts of Parkinson’s disease—a promise that echoes far beyond this single disorder and resonates with the broader quest to unravel the biological rhythms at the core of human health and disease.

Subject of Research: The study investigates the molecular mechanism linking metabolic stress, circadian transcriptional regulation, and Parkinson’s disease, focusing on the glucose-responsive AMPK-TET2-5-hydroxymethylcytosine (5hmC) oscillation.

Article Title: Glucose-responsive AMPK-TET2-5hmc oscillation links metabolic stress to circadian transcription and Parkinson’s disease relevance.

Article References: Chu, L., Wang, S., Wang, L. et al. Glucose-responsive AMPK-TET2-5hmc oscillation links metabolic stress to circadian transcription and Parkinson’s disease relevance. npj Parkinsons Dis. (2026). https://doi.org/10.1038/s41531-026-01447-z

Image Credits: AI Generated

In a groundbreaking revelation that could reshape our understanding of plant-microbe interactions and agricultural biotechnology, researchers have unveiled a novel chemical communication mechanism between rice roots and beneficial soil bacteria. This newly discovered pathway centers on the secretion of heptadecanoic acid, a specific fatty acid, which effectively recruits Bacillus species to the rhizosphere, the densely populated soil region surrounding plant roots. Such a mechanism not only highlights the intricate biochemical dialogues that underpin plant-microbe symbioses but also opens promising avenues for sustainable crop management through microbiome engineering.

Rice, a staple food that sustains more than half of the world’s population, has long been studied for its interactions with the soil ecosystem. The rhizosphere harbors myriad microbial communities, some of which promote plant health by enhancing nutrient acquisition, defending against pathogens, or improving stress tolerance. Identifying the exact signals that facilitate recruitment of beneficial bacteria has presented a considerable scientific challenge. The recent study by Zeng, Wen, Zhao, and colleagues provides essential insights and fills a critical gap by pinpointing heptadecanoic acid as a chemical attractant secreted by rice roots, which acts as a molecular beacon for Bacillus.

Heptadecanoic acid, also known as margaric acid, is a saturated fatty acid containing 17 carbon atoms. Traditionally, plant root exudates—complex mixtures of organic acids, sugars, amino acids, and secondary metabolites—have been observed to influence microbial colonization, but the specific involvement of fatty acids as signals was less appreciated. The team’s meticulous biochemical analyses have now elucidated that rice roots not only exude heptadecanoic acid but do so strategically when recruiting beneficial Bacillus species. This revelation signifies a refined understanding of the selective microbial recruitment strategies employed by plants.

The team’s research employed an array of advanced techniques—ranging from root exudate profiling through gas chromatography-mass spectrometry (GC-MS) to microbial chemotaxis assays—to validate that Bacillus species detect and are attracted to gradients of heptadecanoic acid in the rhizosphere. Importantly, not all soil microbes respond equivalently, underscoring the specificity of this fatty acid signal. Functional studies further demonstrated that disrupting rice root production of heptadecanoic acid diminished Bacillus colonization, which correspondingly weakened the plant’s resistance to common soil-borne pathogens.

Understanding the biochemical basis for such recruitment enables scientists to rethink approaches to crop protection and enhancement. Bacillus species are well-known for their plant growth-promoting traits, including production of antimicrobial compounds, enhancement of nutrient solubilization, and induction of systemic resistance in plants. By harnessing the heptadecanoic acid signaling pathway, it is conceivable that agricultural inoculants could be optimized to improve colonization efficiency and consistency in field conditions, potentially reducing the need for chemical pesticides and fertilizers.

This molecular dialogue highlights a sophisticated communication network where plants actively shape their microbial environment. The discovery that a fatty acid functions not merely as a structural or energy-storage molecule but as a signaling compound redefines our conception of root exudate complexity. Moreover, heptadecanoic acid’s hydrophobic nature prompts questions about its diffusion dynamics in soil and the mechanisms by which Bacillus receptors detect it. Future exploration into bacterial chemoreceptors and downstream signaling pathways activated by this molecule could illuminate novel targets for microbiome manipulation.

Beyond direct agricultural implications, this finding resonates with broader ecological principles. The soil microbiome’s composition significantly influences plant community dynamics, ecosystem productivity, and resilience to environmental stresses. By uncovering a precise mediator of microbe recruitment, the work by Zeng and colleagues contributes to the fundamental ecological theory of plant-soil feedback loops, suggesting that plants possess active biochemical agency in curating their microbial consortia.

Interestingly, the secretion of heptadecanoic acid is not constant but modulated by environmental cues and plant developmental stages, emphasizing the dynamic nature of root exudation profiles. This temporal regulation indicates that plants might selectively recruit beneficial microbes in response to specific physiological needs or external threats, adding an adaptive dimension to this interaction. Understanding these controls could inform timing strategies for microbial inoculant application in agriculture to coincide with natural recruitment periods.

The authors also raise intriguing evolutionary considerations. The conserved ability among rice varieties to secrete heptadecanoic acid suggests selective pressure favoring plants capable of enlisting Bacillus partners. Parallel studies on other cereal crops could reveal whether this fatty acid signaling is a widespread mechanism or unique to rice. Such comparative analyses across plant taxa may unearth a broader family of fatty acid signals mediating symbioses and expand the toolkit for synthetic microbiome engineering.

This pioneering investigation underscores the necessity of interdisciplinary approaches combining plant biology, microbiology, analytical chemistry, and ecology to fully decipher plant-microbe interactions. It leverages cutting-edge omics technologies and bioinformatics pipelines to characterize metabolite profiles and microbial responses, illustrating the power of integrative science. The robust experimental design and reproducible methodologies set a new benchmark for future studies aiming to parse root exudate signaling.

As the global agricultural sector grapples with the challenges of increasing food production sustainably on finite arable land under climate change pressures, the discovery of a natural plant mechanism to recruit growth-promoting and protective microbes represents a potentially transformative tool. Strategies informed by such foundational knowledge could reduce reliance on synthetic inputs, lower environmental footprints, and enhance crop resilience, aligning with ambitious global sustainability goals.

In conclusion, the identification of heptadecanoic acid as a pivotal signaling molecule secreted by rice roots to attract beneficial Bacillus species marks an exciting advance in the field of plant-microbe research. It unravels a previously unrecognized layer of biochemical communication with profound implications for agriculture and ecology. Continued investigation into the molecular details, environmental regulation, and cross-species relevance of this signaling mechanism promises to unlock innovative avenues for crop improvement and sustainable farming practices worldwide.

Subject of Research: Plant-microbe interactions focusing on the biochemical signaling between rice roots and Bacillus species mediated by heptadecanoic acid secretion.

Article Title: Author Correction: Rice roots recruit Bacillus via the secretion of heptadecanoic acid.

Article References: Zeng, J., Wen, T., Zhao, J. et al. Author Correction: Rice roots recruit Bacillus via the secretion of heptadecanoic acid. Nat. Plants (2026). https://doi.org/10.1038/s41477-026-02341-5

Image Credits: AI Generated

In a groundbreaking discovery that could revolutionize the therapeutic approach to oral squamous cell carcinoma (OSCC), researchers have unveiled the intricate role of the circadian gene PER2 in modulating intracellular cholesterol synthesis. This novel mechanistic insight opens new avenues for chronotherapy, particularly enhancing the efficacy of simvastatin, a widely used cholesterol-lowering agent, in combating this aggressive form of cancer.

Oral squamous cell carcinoma remains a significant global health challenge, with limited advancements in effective treatment modalities over the past decades. The cancer’s high propensity for invasiveness and metastasis necessitates innovative strategies that go beyond conventional chemotherapy and radiotherapy. At the cellular level, the adaptation of metabolic pathways, including cholesterol biosynthesis, is increasingly recognized as a hallmark of cancer progression. Cholesterol not only supports membrane biogenesis in rapidly proliferating cancer cells but also acts as a precursor for vital signaling molecules that drive oncogenic pathways.

Central to this study is the circadian clock gene PER2 (Period Circadian Regulator 2), traditionally known for its role in maintaining the body’s biological rhythms. Beyond its canonical function in regulating sleep-wake cycles, PER2 has emerged as a multifaceted regulator of cellular metabolism and tumor suppression. The research team employed a combination of molecular biology techniques, transcriptomic analyses, and in vivo models to delineate how PER2 interfaces with the cholesterol synthesis machinery within cancer cells.

Their findings reveal that PER2 exerts a repressive effect on the mevalonate pathway, the critical metabolic cascade responsible for the generation of cholesterol. Specifically, PER2 downregulates key enzymatic nodes, including HMG-CoA reductase, thereby attenuating the flux of cholesterol precursors. This metabolic reprogramming is pivotal in depriving OSCC cells of essential lipid components required for their malignant behavior, effectively halting tumor growth and invasiveness.

Intriguingly, the study highlights that the endogenous oscillation of PER2 expression within cancer cells aligns with fluctuations in cholesterol synthesis activity. This temporal regulation suggests that the timing of therapeutic intervention could dramatically influence treatment outcomes. Leveraging this insight, the researchers investigated the concept of chronotherapy, administering simvastatin at specific circadian phases to synchronize drug action with the natural troughs in cholesterol biosynthesis dictated by PER2 rhythms.

Experimental paradigms demonstrated a pronounced enhancement in simvastatin’s anticancer efficacy when dosing corresponded with PER2-mediated suppression of cholesterol synthesis. This time-dependent treatment paradigm not only improved tumor regression in preclinical models but also minimized cytotoxic effects on healthy tissues, implying a superior therapeutic index for such chronomodulated regimens.

The implications of these findings extend beyond OSCC treatment, offering a proof-of-concept for integrating circadian biology with metabolic targeting in precision oncology. By harnessing the endogenous biological clock, it may be possible to optimize pharmacodynamics, reduce adverse effects, and overcome resistance mechanisms that have long hindered statin-based anticancer strategies.

Moreover, this research addresses a critical gap in understanding the interplay between clock genes and lipid metabolism in cancer biology. It proposes a cohesive framework where PER2 functions as a metabolic gatekeeper, orchestrating intracellular cholesterol synthesis in a temporally controlled manner that impacts tumorigenicity. The use of simvastatin, a clinically approved HMG-CoA reductase inhibitor, underscores the translational potential of this approach, facilitating rapid clinical adoption and testing in OSCC patients.

The study meticulously dissected the molecular circuitry underlying PER2’s regulatory role, identifying downstream effectors and transcriptional networks that culminate in cholesterol synthesis repression. Through chromatin immunoprecipitation and gene reporter assays, the team uncovered binding sites within promoters of key enzymes, confirming direct transcriptional control. This level of mechanistic detail enriches the conceptual landscape of circadian-metabolic interaction in cancer and provides novel biomarker candidates for therapeutic monitoring.

In vivo experiments employing xenograft models recapitulated the in vitro observations, demonstrating that modulation of PER2 expression modulates tumor growth trajectories. Mice receiving time-tailored simvastatin interventions showed significant tumor volume reduction and improved survival compared to conventional dosing schedules. These data illuminate the potential clinical benefits of integrating circadian timing in cancer drug administration protocols.

Beyond its immediate practical applications, this research invigorates the scientific dialogue around the circadian clock’s influence on cancer metabolism. It challenges researchers to rethink therapeutic strategies by factoring in the temporal dimension of tumor biology. Such chronotherapeutic interventions could ultimately lead to personalized, time-optimized cancer treatments that align with each patient’s molecular circadian profile.

Furthermore, the study invites exploration into combinatorial regimens where PER2 modulation and cholesterol pathway inhibitors act synergistically with immunotherapies or targeted agents. Understanding how circadian regulation interfaces with immune checkpoints and tumor microenvironment dynamics could unlock unprecedented multimodal approaches to OSCC management.

Given the clinical availability and well-characterized safety profile of statins, these findings carry significant translational momentum. Clinical trials designed to evaluate the chronotherapeutic efficacy of simvastatin in OSCC patients are a logical next step, potentially paving the way for novel treatment paradigms that leverage both metabolism and circadian biology.

In summary, this transformative work elucidates a critical metabolic checkpoint governed by the circadian gene PER2, fundamentally altering intracellular cholesterol synthesis and presenting a time-dependent vulnerability in oral squamous cell carcinoma. By aligning pharmacologic intervention with these biological rhythms, the efficacy of simvastatin is markedly enhanced, heralding a new era of chronobiology-informed oncology therapeutics.

As the scientific community continues to unravel the complexities of cancer metabolism and circadian regulation, studies like these underscore the paradigm-shifting potential of integrating diverse biological disciplines. The intersection of chronobiology and cancer metabolism exemplified by PER2’s role may well become a blueprint for future innovations aimed at conquering formidable malignancies such as OSCC.

Subject of Research: The role of the circadian gene PER2 in regulating intracellular cholesterol synthesis and enhancing the chronotherapeutic efficacy of simvastatin in oral squamous cell carcinoma.

Article Title: PER2 reprograms intracellular cholesterol synthesis to inhibit oral squamous cell carcinoma and the chronotherapeutic efficacy of simvastatin.

Article References:
Yin, S., Yang, F., Zhang, Z. et al. PER2 reprograms intracellular cholesterol synthesis to inhibit oral squamous cell carcinoma and the chronotherapeutic efficacy of simvastatin. Cell Death Discov. (2026). https://doi.org/10.1038/s41420-026-03209-5

Image Credits: AI Generated

DOI: https://doi.org/10.1038/s41420-026-03209-5

In a groundbreaking study shedding light on the molecular intricacies of arousal regulation, researchers from Pompeu Fabra University (UPF) and the Centre for Genomic Regulation (CRG) have unveiled the profound influence of neuronal microexons on behavioral states in zebrafish. This study elucidates how subtle alterations in these tiny genetic fragments can trigger hyperarousal—a state marked by heightened neural excitability and pronounced insomnia-like symptoms—which echoes the pathophysiological features observed in various neurodevelopmental disorders. The implications extend far beyond aquatic models, offering a window into the conserved mechanisms of arousal that potentially inform conditions such as autism spectrum disorder and schizophrenia in humans.

Arousal represents a fundamental neurophysiological process essential for survival, enabling organisms to respond to external and internal stimuli with appropriate behavioral and neural adaptations. This highly conserved mechanism across species ensures a meticulously balanced state, modulating responsiveness between lethargy and sensory hypersensitivity. Dysregulation of this balance manifests clinically as either diminished responsiveness or excessive wakefulness and sensory overload, typical hallmarks of stress and various neurodevelopmental pathologies.

Fundamental to this regulatory system is the diversity of proteins synthesized during development and adulthood through alternative splicing—a sophisticated post-transcriptional gene editing process. Alternative splicing enables the generation of multiple functionally distinct protein isoforms from a single gene, often mediated by the inclusion or exclusion of microexons. Microexons are exceptionally short exonic sequences within neuronal genes that profoundly influence protein function and neuronal circuit dynamics despite their minuscule size.

The investigative team employed zebrafish larvae, leveraging their optical transparency and genetic tractability to scrutinize the behavioral consequences of neural microexon misregulation. Larvae exhibiting abnormal microexon patterns demonstrated conspicuous hyperarousal behaviors including disrupted swim patterns and shortened sleep duration. “These larvae not only sleep less frequently but also take considerably longer to initiate sleep,” remarks first author Tahnee Mackensen. This behavioral hyperactivity parallels neural hyperexcitability, suggesting microexon regulation as a pivotal determinant of neurobehavioral states.

At the cellular signaling level, the researchers identified dysregulated cyclic adenosine monophosphate (cAMP) cascades as a key mediator of the observed hyperactive state. cAMP is a ubiquitous second messenger involved in modulating neuronal excitability and synaptic plasticity. The altered splicing of microexons modulates cAMP synthesis and degradation pathways, leading to an aberrant excitation of forebrain neurons in hyperaroused larvae. Notably, this altered cAMP signaling manifests as heightened cAMP-dependent protein kinase A (PKA) activity and subsequent phosphorylation of the transcription factor CREB, implicating the canonical cAMP-PKA-CREB pathway in the regulation of arousal.

The study’s pharmacological interventions underscore the centrality of cAMP regulation in arousal control. Application of cAMP inhibitors normalized the elevated neural activity and behavioral hyperarousal in mutant fish, whereas artificially elevating cAMP in wild-type fish recapitulated the hyperactive phenotype. This bidirectional modulation fortifies the concept that neuronal cAMP levels function as a ‘thermostat’ for arousal states, fine-tuning neuronal excitability and behavioral responsiveness.

Beyond the immediate findings in zebrafish, this research builds upon prior observations in drosophila models demonstrating that microexon disruption similarly impairs sleep and elevates arousal. “The parallel between species indicates an evolutionarily conserved arousal mechanism,” explains Manuel Irimia, senior author. This conservation implies that microexon misregulation, while mechanistically nuanced, may contribute to the neuropsychiatric symptomatology observed in mammals, including humans.

Human neurological disorders such as autism and schizophrenia are often accompanied by sleep disruption and sensory processing anomalies attributed, in part, to aberrant microexon splicing. While microexon alterations are unlikely to be sole causative factors, they may exacerbate or modulate disease phenotypes by disturbing neural excitability homeostasis. These insights prompt a reevaluation of therapeutic strategies aimed at restoring microexon splicing fidelity or modulating cAMP signaling pathways to alleviate neurodevelopmental symptomatology.

Moreover, the link between this microexon-cAMP pathway and mood disorders such as anxiety and depression opens compelling avenues for future research. The cAMP-PKA-CREB axis has well-documented roles in synaptic plasticity and mood regulation, suggesting that microexon-associated dysregulation could contribute to broader neuropsychiatric conditions. “This discovery might just scratch the surface of a complex regulatory network influencing brain function,” notes Mackensen.

The transparency and genetic accessibility of the zebrafish model provided unparalleled opportunities to visualize and quantify internal states through behavioral readouts. Advanced imaging of larval swimming patterns and direct measurement of neurochemical parameters furnished robust correlative evidence linking genetic alterations to functional outcomes. These technical advancements highlight the integrative power of model organisms in neuroscience.

Importantly, this research received support from an array of prestigious funding bodies, including the Horizon 2020 Framework Programme, the Marie Sklodowska-Curie Actions, and the Wellcome Trust, emphasizing the global significance and collaborative nature of this work. The study’s publication in Science Advances confirms its high impact and relevance to the scientific community.

As the team pursues translational studies, the prospect of correcting arousal imbalances by manipulating cAMP pathways or restoring microexon expression presents a promising frontier. This is especially critical given that aberrant arousal and sleep disturbances profoundly impair quality of life in neurodevelopmental disorders. The findings pave the way for multidisciplinary approaches integrating molecular genetics, neurobiology, and pharmacology to develop targeted interventions.

In summation, the identification of neuronal microexons as key modulators of arousal states via the cAMP-PKA-CREB pathway in zebrafish represents a seminal advance in our understanding of the molecular substrates governing complex behavioral phenotypes. This research not only deciphers fundamental biological mechanisms but also holds translational potential to inform therapeutic avenues for neuropsychiatric conditions marked by disrupted arousal and sleep.

Subject of Research: Animals

Article Title: Neuronal microexons modulate arousal via the cAMP-PKA-CREB pathway in zebrafish

News Publication Date: 19-Jun-2026

Web References: 10.1126/sciadv.ady8291

Image Credits: UPF – CRG

Keywords: Exons, Gene splicing, Developmental neuroscience, Anxiety, Sleep disorders, cAMP signaling, Zebrafish

In a groundbreaking study published in Nature Communications, scientists have unveiled how a mitochondrial protein known as OPA3 plays a pivotal role in sustaining cardiac function by regulating calcium handling in male mice. This discovery sheds new light on the intricate cellular mechanisms that underpin heart performance and opens up promising avenues for treating cardiovascular diseases, which remain a leading cause of mortality worldwide. The findings emphasize the critical interplay between mitochondrial dynamics and calcium signaling within cardiac muscle cells, providing a fresh perspective on how cellular energy production influences heart health.

The heart’s ability to maintain rhythmic and efficient contractions is fundamentally dependent on the precise regulation of intracellular calcium levels. Calcium ions serve as essential second messengers in cardiac myocytes, triggering contraction through complex signaling cascades. However, the interplay between calcium dynamics and mitochondrial proteins, especially those involved in mitochondrial morphology and function, has remained elusive until now. The current study identifies the mitochondrial protein OPA3 as a key modulator in this regulatory network, maintaining both mitochondrial integrity and calcium homeostasis crucial for cardiac contractility.

OPA3 is traditionally recognized for its role in maintaining mitochondrial morphology, particularly in mitochondrial fission and fusion processes. These processes are vital for preserving the mitochondrial network’s dynamic nature, which is essential for cellular energy metabolism. Mitochondria not only produce ATP but also buffer intracellular calcium, thereby influencing calcium signaling within cardiac cells. By elucidating how OPA3 influences calcium handling, researchers have bridged an important gap between mitochondrial structural proteins and the functional output of cardiac cells.

Experimental models using male mice engineered for OPA3 depletion revealed significant impairments in cardiac function, demonstrating that loss of OPA3 disrupts calcium cycling in cardiac myocytes. Impaired calcium handling directly correlates with diminished contractile force and defective cardiac output. This suggests that OPA3’s influence extends beyond structural maintenance and into functional regulation of calcium channels or transporters. The dysregulation of such a critical ion pathway can lead to arrhythmias and cardiac failure, underscoring the potential clinical significance of these findings.

At the molecular level, the study highlights that OPA3 affects the expression and activity of key calcium regulators including the sarcoplasmic reticulum Ca2+ ATPase (SERCA) and ryanodine receptors (RyR). These proteins govern calcium reuptake and release in cardiac cells, orchestrating contraction and relaxation cycles. Through advanced imaging and electrophysiological techniques, the research team demonstrated that OPA3 deficiency impairs SERCA function and causes aberrant RyR-mediated calcium leak, leading to calcium overload or deficits. Such pathophysiological alterations are known contributors to cardiac hypertrophy and heart failure in humans.

The investigation also explores the bioenergetic consequences of OPA3 modulation. Mitochondrial bioenergetics in cardiac muscle cells are highly tuned to meet the energy demands of continuous contractions. OPA3 deficiency was found to compromise mitochondrial ATP production by disrupting inner membrane potential and electron transport chain efficiency. These mitochondrial defects culminate in inadequate energy supply for calcium pumps and ion exchangers, further exacerbating contractile dysfunction. This uncovers a feedback loop where structural mitochondrial proteins like OPA3 indirectly regulate calcium handling by maintaining energetic homeostasis.

A remarkable aspect of the study lies in its use of state-of-the-art imaging techniques such as live-cell confocal microscopy and super-resolution electron microscopy, which revealed morphological abnormalities in mitochondria lacking OPA3. Fragmented and swollen mitochondria with disrupted cristae architecture were prevalent in OPA3-deficient cardiomyocytes. These structural derangements are likely responsible for the observed bioenergetic failures and altered calcium buffering capacity, collectively impairing the cardiomyocyte’s functional integrity.

Furthermore, the team utilized optogenetics-based calcium sensors to monitor real-time calcium flux in isolated cardiomyocytes, providing unprecedented insight into how OPA3 influences calcium transients during excitation-contraction coupling. Data revealed that OPA3 loss leads to prolonged calcium decay time and increased diastolic calcium levels, conditions that predispose cardiac cells to arrhythmic events and contractile inefficiency. These calcium handling anomalies could explain the pathophysiology of certain forms of cardiomyopathy linked to mitochondrial dysfunction.

Importantly, the study addresses the potential sex-specific roles of OPA3, noting that experiments were conducted exclusively in male mice to control for hormonal influences on cardiac physiology. This raises intriguing questions about whether OPA3 functions similarly in female models and whether sex hormones modulate its expression or activity. Such considerations are critical as sex differences in cardiovascular disease outcomes are well-documented, emphasizing the need for further research in this domain.

The translational implications of these findings are profound. Therapeutic strategies aimed at restoring or enhancing OPA3 function could stabilize mitochondrial morphology and bioenergetics, thereby normalizing calcium handling and improving cardiac contractility. Such interventions might hold promise for treating heart failure syndromes characterized by mitochondrial and calcium dysregulation. Moreover, identifying small molecules or gene therapies targeting OPA3 pathways might complement existing treatments that primarily focus on calcium channels but neglect mitochondrial contributions.

Beyond the heart, the role of OPA3 in mitochondrial dynamics suggests potential relevance in other tissues with high energetic demand, such as skeletal muscle and the brain. Defects in mitochondrial morphology and calcium handling have been implicated in neurodegenerative diseases and metabolic disorders. Thus, understanding OPA3’s function could have broad implications in diverse biomedical fields, making it a protein of significant interest in physiology and pathophysiology.

This study also raises several compelling scientific questions for future research. How does OPA3 interact with other mitochondrial fission and fusion proteins, such as OPA1, MFN1/2, and DRP1, in regulating calcium signaling? What are the upstream regulators of OPA3 expression in cardiac tissue under physiological and pathological conditions? Additionally, can OPA3 modulation reverse established cardiac dysfunction or is it mainly preventive? Addressing these queries will deepen our understanding of cardiac mitochondrial biology and pave the way for novel therapeutic innovations.

Addressing cardiac diseases from a mitochondrial perspective represents a paradigm shift in cardiovascular medicine. Historically, calcium handling has been studied primarily through its direct regulators, but this research highlights the necessity of considering mitochondrial proteins like OPA3 as integral components of intracellular calcium homeostasis. This refined viewpoint may revolutionize how clinicians and scientists approach diagnosis, prognosis, and treatment of cardiac ailments.

In conclusion, the identification of mitochondrial protein OPA3 as a fundamental regulator of cardiac calcium handling marks a significant advance in cardiovascular biology. By elucidating the link between mitochondrial morphology, energy metabolism, and calcium signaling, this work provides critical insights into the molecular basis of cardiac function and dysfunction. It offers hope for innovative interventions that could alleviate the burden of heart disease, fostering improved patient outcomes and advancing the frontier of precision medicine in cardiology.

Subject of Research:
Mitochondrial protein OPA3 and its role in cardiac function via regulation of intracellular calcium handling mechanisms.

Article Title:
Mitochondrial protein OPA3 sustains cardiac function by regulating calcium handling in male mice.

Article References:
Geng, N., Chen, T., Li, H. et al. Mitochondrial protein OPA3 sustains cardiac function by regulating calcium handling in male mice. Nat Commun (2026). https://doi.org/10.1038/s41467-026-73991-4

Image Credits: AI Generated

In a groundbreaking study published recently, researchers have uncovered a pivotal molecular mechanism driving the aggressive behavior of lung cancer cells. The investigation centers around the microRNA miR-9-5p, a small non-coding RNA molecule intricately regulated by the kinase IKKα. This discovery elucidates how miR-9-5p orchestrates lung tumor growth and invasiveness through the modulation of the CDH1/Wnt/β-catenin signaling pathway, a critical axis in cell adhesion and proliferation. As lung cancer remains the leading cause of cancer-related mortality worldwide, identifying such novel regulatory mechanisms holds immense promise for therapeutic innovation.

The research team, led by Besta, S., Roupakia, E., and Kanaki, Z., meticulously dissected the molecular interplay governing miR-9-5p expression and function within the intricate cancer signaling environment. Their study highlights that IKKα, beyond its established role in the NF-κB pathway, exerts fine-tuned control over this specific microRNA, effectively shaping the oncogenic landscape. Through a series of advanced molecular assays, including chromatin immunoprecipitation and luciferase reporter analyses, the researchers demonstrated that IKKα activity directly influences miR-9-5p transcriptional dynamics, pointing to a novel layer of regulatory complexity.

miR-9-5p has previously been implicated in various malignancies, yet its precise contributions remained ambiguous. This study definitively links miR-9-5p to the suppression of CDH1 (E-cadherin), a hallmark molecule responsible for maintaining epithelial integrity. Loss of E-cadherin function is a well-recognized driver of epithelial-to-mesenchymal transition (EMT), a process by which cancer cells gain migratory and invasive capabilities. By downregulating CDH1 via miR-9-5p, lung cancer cells effectively dismantle their adhesion properties, facilitating dissemination and metastasis.

Integral to this regulatory network is the activation of the canonical Wnt/β-catenin signaling pathway, which the study identifies as a downstream consequence of CDH1 suppression. β-catenin, a multifunctional protein, plays dual roles in cell-cell adhesion complexes and nuclear transcriptional activation. Dysregulation of this pathway is a hallmark of many cancers, contributing not only to uncontrolled proliferation but also to resistance against therapeutic interventions. The newfound connection between miR-9-5p and Wnt/β-catenin signaling unravels a compelling oncogenic circuit poised for targeted intervention.

Using lung cancer cell lines and patient-derived tumor samples, the investigators provided robust evidence that overexpression of miR-9-5p correlates with heightened tumor aggressiveness and poor clinical outcomes. Functional analyses revealed that silencing miR-9-5p reinstituted CDH1 expression, attenuating invasive behaviors and restoring epithelial characteristics. These findings propel miR-9-5p into the spotlight as a master regulator capable of toggling cancer cell phenotype and metastatic potential.

Of notable significance is the implication of IKKα as the upstream modulator of this microRNA. Historically recognized for its pivotal function in inflammatory signaling cascades, IKKα’s emerging role in microRNA regulation bridges inflammation and oncogenesis at a molecular crossroads. This intersection offers exciting prospects for therapeutic targeting, as dual inhibition could suppress both pro-tumorigenic inflammation and invasive cancer phenotypes mediated through miR-9-5p.

The authors leveraged state-of-the-art sequencing technologies to map genome-wide interactions, confirming that IKKα binds specific regulatory elements proximal to the miR-9-5p gene locus. This direct interaction suggests that pharmacological modulation of IKKα kinase activity might effectively recalibrate microRNA expression profiles, thus impairing tumorigenic signaling networks at their root. Such mechanistic insights lay the foundation for developing precision medicines tailored to disrupt this pathogenic axis.

Lung cancer, notorious for its heterogeneity and adaptability, frequently evades conventional therapies through mechanisms such as EMT and Wnt pathway activation. Unraveling the molecular underpinnings of these processes, as achieved by this work, enables the design of novel intervention strategies that could circumvent drug resistance. By targeting miR-9-5p or its regulatory kinase IKKα, future treatments may convert invasive tumors into more differentiated, therapeutically vulnerable states.

Importantly, the study’s exploration of the IKKα-miR-9-5p-CDH1/Wnt axis underscores the interconnectedness of signaling pathways and gene regulatory networks in cancer biology. Such systems-level understanding propels the field beyond isolated gene targets toward integrated models that better predict treatment responses and disease progression. The findings thus represent a paradigm shift in conceptualizing lung cancer’s molecular circuitry.

Beyond its biological implications, this discovery carries significant translational potential. miR-9-5p could serve as a biomarker for aggressive lung cancers, guiding treatment decisions and prognostic assessments. Additionally, small molecule inhibitors or RNA-based therapeutics designed to disrupt IKKα activity or miR-9-5p function may augment existing regimens, potentially enhancing survival rates and quality of life for patients afflicted with this formidable disease.

This study also invites deeper inquiry into whether similar regulatory modules operate in other cancer types, given the conserved roles of IKKα, miR-9-5p, and the Wnt pathway across tissues. Such cross-cancer analyses could reveal universal principles of tumor biology and expand the therapeutic utility of targeting this molecular axis. The research thus sets the stage for broader investigations with wide-reaching clinical impact.

Mechanistically, the intricate balance between miR-9-5p-mediated repression of CDH1 and activation of Wnt/β-catenin signaling exemplifies how microRNAs act as critical nodes in signaling networks. By fine-tuning gene expression post-transcriptionally, microRNAs integrate diverse signals to execute complex cellular programs that dictate tumor behavior. The elucidation of this IKKα-microRNA module enriches our comprehension of non-coding RNA-mediated oncogenic regulation.

Furthermore, the work elucidates how inflammatory kinases such as IKKα intersect with epigenetic and transcriptional machinery to modulate microRNA landscapes. This context expands the conceptual framework of inflammation-driven carcinogenesis, linking kinase signaling, chromatin remodeling, and RNA biology. Therapeutic strategies arising from such multi-dimensional insights promise higher specificity and efficacy.

In summary, this seminal research sheds light on an uncharted regulatory cascade central to lung cancer aggressiveness. By mapping how IKKα drives the expression of the microRNA miR-9-5p, which in turn orchestrates CDH1 repression and Wnt/β-catenin pathway activation, the study unravels a critical oncogenic driver. These insights open new avenues for targeted therapies, potentially revolutionizing treatment paradigms for one of the deadliest human malignancies.

With the rapid advancement of molecular oncology, understanding how kinases, non-coding RNAs, and signaling pathways cooperate to fuel tumor progression is paramount. This research epitomizes the progress toward a more nuanced, mechanism-based approach for combatting lung cancer. As future studies build on these foundational discoveries, hope grows for effective interventions that can halt or reverse malignancy’s deadly march.

Ultimately, the revelation of the IKKα-miR-9-5p-CDH1/Wnt axis heralds a new era of lung cancer biology, emphasizing the power of integrated molecular approaches in uncovering therapeutic targets. The ongoing challenge lies in translating these findings from bench to bedside, a pursuit fueled by the promise of improving patient outcomes and conquering cancer’s complexity.

Subject of Research: The regulatory role of IKKα in modulating the microRNA miR-9-5p and its impact on lung cancer growth and invasiveness via the CDH1/Wnt/β-catenin signaling pathway.

Article Title: The IKKα-regulated microRNA miR-9-5p mediates lung cancer growth and invasiveness via CDH1/Wnt/β-catenin signalling.

Article References: Besta, S., Roupakia, E., Kanaki, Z. et al. The IKKα-regulated microRNA miR-9-5p mediates lung cancer growth and invasiveness via CDH1/Wnt/β-catenin signalling. Cell Death Discov. (2026). https://doi.org/10.1038/s41420-026-03195-8

Image Credits: AI Generated

DOI: https://doi.org/10.1038/s41420-026-03195-8

In a groundbreaking discovery that broadens our understanding of marine life communication, researchers at Oregon State University have identified a novel chemical signaling mechanism among bat rays (Myliobatis californica) that warns conspecifics of looming threats. This chemical disturbance cue, previously documented only in bony fish, now emerges as a key anti-predator strategy in cartilaginous fishes—specifically rays—revealing a layer of behavioral complexity that challenges long-held assumptions about elasmobranch social interactions.

Dr. Joshua Bowman, leading the study from OSU’s Big Fish Lab, devised an elegant experimental setup employing three isolated tanks interconnected through water flow but segregated visually and acoustically to eliminate confounding sensory influences. Each tank housed an individual bat ray, with one designated as the “signaler” and the other two as “receivers.” By simulating predatory pressure through a gentle chase of the signaler ray, the experimenters induced a natural defensive response while ensuring no physical harm.

Strikingly, within mere seconds of the signaler tank’s water being directed towards the receiver tanks, the bat rays in these isolated environments exhibited marked behavioral shifts characterized by increased swimming speed and evasive maneuvers. These responses mimic a flight reaction, confirming the transfer of a chemical alarm cue through the aquatic medium—a sensory pathway previously undocumented in cartilaginous species.

This discovery bears profound implications for understanding elasmobranch ecology and survival strategies. Bat rays, along with sharks and skates, belong to a class of cartilaginous fishes characterized by their distinct evolutionary lineage and physiology. These findings suggest sophisticated intraspecies chemical communication channels functioning as early-warning systems against predation risks, potentially reshaping our perception of their behavioral ecology.

Moreover, the research carries significance beyond bat rays. Whites sharks, apex predators renowned for their fearsome reputation, are known to exhibit avoidance behaviors when orcas, their potential predators, are nearby. Yet, these sharks often do not have direct visual contact with orcas. This study’s insights into chemical alarm signaling hint at unseen communication mechanisms that might underlie such evasive behavior, opening new avenues for exploration into shark sensory biology and their interactions within the marine predator-prey network.

The experiment’s methodological rigor enhances the credibility of these findings. By isolating variables—eliminating acoustic and visual cues—the team conclusively linked behavioral changes to chemical signals. High-resolution overhead video recordings captured nuanced shifts in locomotion dynamics, quantitatively analyzing the rays’ rapid swimming velocity increases immediately following exposure to the alarm chemicals. These data underscore a robust flight response triggered solely by chemical disturbance cues.

While the precise chemical compound or combination responsible for the alarm signaling remains unidentified, the study establishes a foundation for future biochemical and molecular investigations. Identifying the molecular structure of the alarm cue could unlock transformative understandings of elasmobranch chemical ecology, potentially informing conservation strategies and offering biomarkers for monitoring stress responses in marine populations.

Importantly, the research foregrounds broader ecological and ethical considerations. The evolutionary origin of these chemical disturbance cues underscores their critical role in survival and natural behavior modulation. Human interactions—whether through scientific research, fisheries, or recreational activities—may inadvertently trigger stress dissemination across populations via such chemical signals, amplifying disturbance impacts beyond the initially affected individual.

The OSU Big Fish Lab, recognized as a leading shark research facility on the U.S. West Coast, continues to spearhead innovative studies uncovering the intricate lives of marine cartilaginous fishes. This collaboration, involving co-authors Jamie Cornelius and Mauricio Cantor, integrates expertise spanning marine ecology, physiology, and animal behavior, thereby enhancing multidisciplinary perspectives crucial to advancing marine science frontiers.

By employing bat rays as a proxy for studying elusive white shark behavior, the researchers circumvent logistical challenges inherent to large predator studies. Bat rays’ accessibility and manageable size provide an ethical and practical model to dissect communication modalities applicable across related species, ensuring experimental feasibility while preserving ecological validity.

This study, recently published in the Journal of Experimental Zoology Part A: Ecological and Integrative Physiology, represents a significant milestone in marine biology. It not only documents, for the first time, chemically mediated disturbance cues in cartilaginous fishes but also stimulates critical reflection on the sensory worlds of sharks and rays, organisms whose behavioral sophistication may be far richer than previously appreciated.

Collectively, these findings herald a paradigm shift in our understanding of underwater communication networks. They remind us that aquatic ecosystems host complex, often hidden, language systems integral to species survival. As we deepen our inquiry into these chemical dialogues, we unlock new insights essential for protecting marine biodiversity in a rapidly changing ocean environment.

Subject of Research: Animals
Article Title: Behavioral Evidence for a Chemical Disturbance Cue in Bat Rays (Myliobatis californica)
News Publication Date: 10-Jun-2026
Web References: http://dx.doi.org/10.1002/jez.70102
References: Journal of Experimental Zoology Part A: Ecological and Integrative Physiology
Keywords: chemical disturbance cue, bat rays, cartilaginous fish, elasmobranchs, shark behavior, marine communication, anti-predator strategy, predator-prey interactions, aquatic chemical signaling, flight response, marine ecology, behavioral study